Cytomegalovirus (CMV) Infection in Pregnancy

计划入组 283 人 · 首次发布于 2005 年 9 月 19 日

CMV Infection in Adolescent Males

计划入组 411 人 · 首次发布于 2006 年 3 月 13 日

Cytomegalovirus (CMV) Infection in Amniotic Fluid

计划入组 37 人 · 首次发布于 2005 年 9 月 19 日

Retro-94

allogeneic anti-CMV-TCR-T-cell therapy (CMV infection after HSCT)

Maribavir(Livtencity)

C₁₅H₁₉Cl₂N₃O₄ · Rx

FIRST MEDICAL INFECTION CONTROL ASSOCIATES, INC.

United States

B. Braun Ltd. Centre of Excellence Infection Control

AstraZeneca

United Kingdom

Kamada Initiates SHIELD Trial to Prevent Late CMV Infection in High-Risk Kidney Transplant Recipients

CMV Treatment Pipeline Expands with 20+ Therapies from Leading Pharmaceutical Companies

New Zealand Proposes Public Funding for Letermovir to Prevent Life-Threatening CMV Infections After Stem Cell Transplants